Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

INDUSTRY 2 OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1 Dermatologic 1

Conditions

Mycosis Fungoides 1 Lymphoma, T-Cell, Cutaneous 1

Interventions

pembrolizumab 589 Cyclophosphamide 539 Magnetic Resonance Spectroscopy 523 Radiotherapy 506 Specimen Handling 503 Nivolumab 407 Cisplatin 370 Carboplatin 358 Biopsy 304 Blood Specimen Collection 295 Radiosurgery 283 Paclitaxel 274 Surveys and Questionnaires 268 Standard of Care 266 Gemcitabine 265 fludarabine 261 Dexamethasone 258 Drug Therapy 256 venetoclax 246 Bevacizumab 246 Oxaliplatin 206 Rituximab 195 Capecitabine 194 Radiation 189 Fluorouracil 186 Ipilimumab 184 durvalumab 180 Doxorubicin 175 atezolizumab 172 Etoposide 171

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × hypericin × 1 year × Clear all

NCT05872854 2026-02-09

RW-HPN-MF-01

Abramson Cancer Center at Penn Medicine

Phase 2 Completed

DermatologicLymphoid

Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon ⚡